{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T00:40:03Z","timestamp":1737333603690,"version":"3.33.0"},"reference-count":40,"publisher":"Japanese Pharmacological Society","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Pharmacol Sci"],"published-print":{"date-parts":[[2007]]},"DOI":"10.1254\/jphs.fp0070294","type":"journal-article","created":{"date-parts":[[2007,7,30]],"date-time":"2007-07-30T05:50:11Z","timestamp":1185774611000},"page":"218-224","source":"Crossref","is-referenced-by-count":10,"title":["Effects of Loperamide on Mechanical Allodynia Induced by Herpes Simplex Virus Type-1 in Mice"],"prefix":"10.1254","volume":"104","author":[{"given":"Atsushi","family":"Sasaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasutaka","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ichiro","family":"Takasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsugunobu","family":"Andoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimiyasu","family":"Shiraki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Kuraishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"332","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Stein C. The control of pain in peripheral tissue by opioids. N Engl J Med. 1995;332:1685–1690.","DOI":"10.1056\/NEJM199506223322506"},{"issue":"1 Pt 1","key":"2","first-page":"165","volume":"15","year":"1995","ISSN":"https:\/\/id.crossref.org\/issn\/0270-6474","issn-type":"print"},{"issue":"1","key":"3","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S0022-3565(24)38161-3","volume":"289","author":"DEHAVEN-HUDKINS D L","year":"1999","ISSN":"https:\/\/id.crossref.org\/issn\/0022-3565","issn-type":"print"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Zöllner C, Shaqura MA, Bopaiah CP, Mousa S, Stein C, Schäfer M. Painful inflammation-induced increase in μ-opioid receptor binding and G-protein coupling in primary afferent neurons. Mol Pharmacol. 2003;64:202–210.","DOI":"10.1124\/mol.64.2.202"},{"issue":"15","key":"5","doi-asserted-by":"crossref","first-page":"5935","DOI":"10.1073\/pnas.87.15.5935","volume":"87","year":"1990","ISSN":"https:\/\/id.crossref.org\/issn\/0027-8424","issn-type":"print"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Wenk HN, Brederson JD, Honda CN. Morphine directly inhibits nociceptors in inflamed skin. J Neurophysiol. 2006;95:2083–2097.","DOI":"10.1152\/jn.00394.2005"},{"issue":"1","key":"7","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0022-3565(24)34891-8","volume":"290","author":"KOLESNIKOV Y","year":"1999","ISSN":"https:\/\/id.crossref.org\/issn\/0022-3565","issn-type":"print"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Schinkel AH, Wagenaar E, Mol CA, van Deemter L. P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs. J Clin Invest. 1996;97:2517–2524.","DOI":"10.1172\/JCI118699"},{"key":"9","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-199901000-00029"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Stein C, Pfluger M, Yassouridis A, Hoelzl J, Lehrberger K, Welte C, et al. No tolerance to peripheral morphine analgesia in presence of opioid expression in inflamed synovia. J Clin Invest. 1996;98:793–799.","DOI":"10.1172\/JCI118852"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Watterson G, Howard R, Goldman A. Peripheral opioids in inflammatory pain. Arch Dis Child. 2004;89:679–681.","DOI":"10.1136\/adc.2003.032003"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3959(86)90089-8"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Haanpaa M, Laippala P, Nurmikko T. Pain and somatosensory dysfunction in acute herpes zoster. Clin J Pain. 1999;15:78–84.","DOI":"10.1097\/00002508-199906000-00003"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Douglas MW, Johnson RW, Cunningham AL. Tolerability of treatments for postherpetic neuralgia. Drug Saf. 2004;27:1217–1233.","DOI":"10.2165\/00002018-200427150-00005"},{"key":"15","unstructured":"15 Lancaster T, Silagy C, Gray S. Primary care management of acute herpes zoster: systematic review of evidence from randomized controlled trials. Br J Gen Pract. 1995;45:39–45."},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Straus SE, Ostrove JM, Inchauspe G, Felser JM, Freifeld A, Croen KD, et al. NIH conference. Varicella-zoster virus infections. Biology, natural history, treatment, and prevention. Ann Intern Med. 1988;108:221–237.","DOI":"10.7326\/0003-4819-108-2-221"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3959(00)00240-2"},{"key":"18","doi-asserted-by":"publisher","DOI":"10.1254\/jjp.83.319"},{"key":"19","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3959(83)90201-4"},{"key":"20","doi-asserted-by":"publisher","DOI":"10.1016\/S0028-3908(01)00173-3"},{"issue":"3","key":"21","first-page":"1535","volume":"275","year":"1995","ISSN":"https:\/\/id.crossref.org\/issn\/0022-3565","issn-type":"print"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Takasaki I, Suzuki T, Sasaki A, Nakao K, Hirakata M, Okano K, et al. Suppression of acute herpetic pain-related responses by the kappa-opioid receptor agonist (−)-17-cyclopropylmethyl-3,14beta-dihydroxy-4,5alpha-epoxy-beta-[n-methyl-3-trans-3-(3-furyl) acrylamido] morphinan hydrochloride (TRK-820) in mice. J Pharmacol Exp Ther. 2004;309:36–41.","DOI":"10.1124\/jpet.103.059816"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Shinoda K, Hruby VJ, Porreca F. Antihyperalgesic effects of loperamide in a model of rat neuropathic pain are mediated by peripheral delta-opioid receptors. Neurosci Lett. 2007;411:143–146.","DOI":"10.1016\/j.neulet.2006.10.027"},{"key":"24","doi-asserted-by":"publisher","DOI":"10.1254\/jphs.FPJ05011X"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Menendez L, Lastra A, Meana A, Hidalgo A, Baamonde A. Analgesic effects of loperamide in bone cancer pain in mice. Pharmacol Biochem Behav. 2005;81:114–121.","DOI":"10.1016\/j.pbb.2005.02.007"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Stein C, Schäfer M, Machelska H. Attacking pain at its source: new perspectives on opioids. Nat Med. 2003;9:1003–1008.","DOI":"10.1038\/nm908"},{"issue":"12","key":"27","doi-asserted-by":"crossref","first-page":"8156","DOI":"10.1523\/JNEUROSCI.15-12-08156.1995","volume":"15","year":"1995","ISSN":"https:\/\/id.crossref.org\/issn\/0270-6474","issn-type":"print"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Puehler W, Zöllner C, Brack A, Shaqura MA, Krause H, Schäfer M, et al. Rapid upregulation of μ opioid receptor mRNA in dorsal root ganglia in response to peripheral inflammation depends on neuronal conduction. Neuroscience. 2004;129:473–479.","DOI":"10.1016\/j.neuroscience.2004.06.086"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29 Takasaki I, Nojima H, Shiraki K, Kuraishi Y. Specific down-regulation of spinal μ-opioid receptor and reduced analgesic effects of morphine in mice with postherpetic pain. Eur J Pharmacol. 2006;550:62–67.","DOI":"10.1016\/j.ejphar.2006.08.041"},{"issue":"4","key":"30","first-page":"731","volume":"44","year":"1993","ISSN":"https:\/\/id.crossref.org\/issn\/0026-895X","issn-type":"print"},{"issue":"4539","key":"31","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1126\/science.7199758","volume":"215","year":"1982","ISSN":"https:\/\/id.crossref.org\/issn\/0036-8075","issn-type":"print"},{"key":"32","doi-asserted-by":"publisher","DOI":"10.1016\/0028-3908(91)90120-Z"},{"issue":"8","key":"33","doi-asserted-by":"crossref","first-page":"4806","DOI":"10.1523\/JNEUROSCI.14-08-04806.1994","volume":"14","year":"1994","ISSN":"https:\/\/id.crossref.org\/issn\/0270-6474","issn-type":"print"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34 Mitchell JM, Basbaum AI, Fields HL. A locus and mechanism of action for associative morphine tolerance. Nat Neurosci. 2000;3:47–53.","DOI":"10.1038\/71120"},{"key":"35","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(92)90078-L"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36 Chung S, Pohl S, Zeng J, Civelli O, Reinscheid RK. Endogeneous orphanin FQ\/nociceptin is involved in the development of morphine tolerance. J Pharmacol Exp Ther. 2006;318:262–267.","DOI":"10.1124\/jpet.106.103960"},{"key":"37","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3940(99)00285-2"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38 Ueda H, Matsunaga S, Inoue M, Yamamoto Y, Hazato T. Complete inhibition of purinoceptor agonit-induced nociception by spinorphin, but not morphine. Peptides. 2000;21:1215–1221.","DOI":"10.1016\/S0196-9781(00)00262-X"},{"key":"39","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-6147(00)01616-3"},{"key":"40","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(95)00757-Z"}],"container-title":["Journal of Pharmacological Sciences"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T00:24:19Z","timestamp":1737332659000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/jphs\/104\/3\/104_3_218\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1254\/jphs.fp0070294","relation":{},"ISSN":["1347-8613","1347-8648"],"issn-type":[{"type":"print","value":"1347-8613"},{"type":"electronic","value":"1347-8648"}],"subject":[],"published":{"date-parts":[[2007]]}}}